Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2024

13-01-2024 | Gastric Cancer | Original Article

Hsa_circ_0014606 Derived from Exosomes Promotes Gastric Carcinoma Tumorigenesis and Proliferation by Sponging miR-514b-3p to Upregulate HNRNPC

Authors: Tao Jiang, Lingling Xu, Xiaona Qu, Rui Li, Ye Cheng, Hongmei He

Published in: Digestive Diseases and Sciences | Issue 3/2024

Login to get access

Abstract

Gastric cancer is a common malignant tumor, and due to its insidious onset and limited screening methods, most patients are diagnosed with advanced disease and have a poor prognosis. The circRNA in exosomes has an essential role in cancer diagnosis and treatment. However, the part of hsa_circ_0014606 within exosomes in gastric cancer progression is unclear. Firstly, we extracted exosomes from the serum of gastric cancer patients and healthy individuals by ultracentrifugation and analyzed the expression of hsa_circ_0014606 in both exosomes; then knocked down hsa_circ_0014606 in vivo and in vitro, respectively, to observe its effect on the physiological function of gastric cancer cells; finally, we used bioinformatics to screen hsa_circ_0014606 targeting miRNAs and mRNAs, and experiments were performed to verify the interrelationship between the three. The results showed that the level of hsa_circ_0014606 in the serum exosomes of gastric cancer patients was significantly higher than that of the healthy population. The knockdown of hsa_circ_0014606 slowed the proliferation of gastric cancer cells, significantly reduced migration and invasion ability, accelerated apoptosis, and reduced tumor size in mice. In addition, the expression of hsa_circ_0014606 was negatively correlated with the expression of miR-514b-3p and positively correlated with the expression of heterogeneous nuclear ribonucleoprotein C (HNRNPC). In conclusion, hsa_circ_0014606 exerted a pro-cancer effect indirectly through miR-514b-3p targeting gene HNRNPC, and this study provides a new potential target for treating gastric cancer.
Literature
2.
go back to reference Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy. 2022;54(6):591–622.CrossRefPubMed Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy. 2022;54(6):591–622.CrossRefPubMed
3.
go back to reference Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology. 2022;33(10):1005–1020.CrossRefPubMed Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology. 2022;33(10):1005–1020.CrossRefPubMed
4.
go back to reference Li S, Zhang M, Zhang H, et al. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer. Clinica chimica acta; international journal of clinical chemistry. 2020;501:252–257.CrossRefPubMed Li S, Zhang M, Zhang H, et al. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer. Clinica chimica acta; international journal of clinical chemistry. 2020;501:252–257.CrossRefPubMed
5.
go back to reference Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2022;20(2):167–192.CrossRefPubMed Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2022;20(2):167–192.CrossRefPubMed
6.
go back to reference Allum W, Lordick F, Alsina M, et al. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Critical reviews in oncology/hematology. 2018;122:179–193.CrossRefPubMed Allum W, Lordick F, Alsina M, et al. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Critical reviews in oncology/hematology. 2018;122:179–193.CrossRefPubMed
7.
go back to reference Vasconcelos MH, Caires HR, Ābols A, Xavier CPR, Linē A. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 2019;47:100647.CrossRefPubMed Vasconcelos MH, Caires HR, Ābols A, Xavier CPR, Linē A. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 2019;47:100647.CrossRefPubMed
8.
go back to reference Zhang XY, Zhang PY. Gastric cancer: somatic genetics as a guide to therapy. Journal of medical genetics. 2017;54(5):305–312.CrossRefPubMed Zhang XY, Zhang PY. Gastric cancer: somatic genetics as a guide to therapy. Journal of medical genetics. 2017;54(5):305–312.CrossRefPubMed
9.
go back to reference Leja M, Linē A. Early detection of gastric cancer beyond endoscopy - new methods. Best practice & research Clinical gastroenterology. 2021;50–51:101731.CrossRefPubMed Leja M, Linē A. Early detection of gastric cancer beyond endoscopy - new methods. Best practice & research Clinical gastroenterology. 2021;50–51:101731.CrossRefPubMed
10.
go back to reference Meldolesi J. Exosomes and Ectosomes in Intercellular Communication. Current biology: CB. 2018;28(8):R435-r444.CrossRefPubMed Meldolesi J. Exosomes and Ectosomes in Intercellular Communication. Current biology: CB. 2018;28(8):R435-r444.CrossRefPubMed
11.
go back to reference Kok VC, Yu CC. Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development. International journal of nanomedicine. 2020;15:8019–8036.CrossRefPubMedPubMedCentral Kok VC, Yu CC. Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development. International journal of nanomedicine. 2020;15:8019–8036.CrossRefPubMedPubMedCentral
12.
go back to reference Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal transduction and targeted therapy. 2020;5(1):145.CrossRefPubMedPubMedCentral Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal transduction and targeted therapy. 2020;5(1):145.CrossRefPubMedPubMedCentral
13.
go back to reference Xu Z, Chen Y, Ma L, et al. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Molecular therapy: the journal of the American Society of Gene Therapy. 2022;30(10):3133–3154.CrossRefPubMed Xu Z, Chen Y, Ma L, et al. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Molecular therapy: the journal of the American Society of Gene Therapy. 2022;30(10):3133–3154.CrossRefPubMed
14.
go back to reference Vahabi A, Rezaie J, Hassanpour M, et al. Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities. Biochemical pharmacology. 2022;200:115038.CrossRefPubMed Vahabi A, Rezaie J, Hassanpour M, et al. Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities. Biochemical pharmacology. 2022;200:115038.CrossRefPubMed
15.
go back to reference Lin Y, Zheng ZH, Wang JX, Zhao Z, Peng TY. Tumor Cell-Derived Exosomal Circ-0072088 Suppresses Migration and Invasion of Hepatic Carcinoma Cells Through Regulating MMP-16. Frontiers in cell and developmental biology. 2021;9:726323.CrossRefPubMedPubMedCentral Lin Y, Zheng ZH, Wang JX, Zhao Z, Peng TY. Tumor Cell-Derived Exosomal Circ-0072088 Suppresses Migration and Invasion of Hepatic Carcinoma Cells Through Regulating MMP-16. Frontiers in cell and developmental biology. 2021;9:726323.CrossRefPubMedPubMedCentral
16.
go back to reference Rao M, Zhu Y, Qi L, Hu F, Gao P. Circular RNA profiling in plasma exosomes from patients with gastric cancer. Oncology letters. 2020;20(3):2199–2208.CrossRefPubMedPubMedCentral Rao M, Zhu Y, Qi L, Hu F, Gao P. Circular RNA profiling in plasma exosomes from patients with gastric cancer. Oncology letters. 2020;20(3):2199–2208.CrossRefPubMedPubMedCentral
17.
go back to reference Iwai K, Minamisawa T, Suga K, Yajima Y, Shiba K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. Journal of extracellular vesicles. 2016;5:30829.CrossRefPubMed Iwai K, Minamisawa T, Suga K, Yajima Y, Shiba K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. Journal of extracellular vesicles. 2016;5:30829.CrossRefPubMed
19.
go back to reference Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY) 2020;367(6478). Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY) 2020;367(6478).
20.
go back to reference Daßler-Plenker J, Küttner V, Egeblad M. Communication in tiny packages: Exosomes as means of tumor-stroma communication. Biochimica et biophysica acta Reviews on cancer. 2020;1873(2):188340.CrossRefPubMed Daßler-Plenker J, Küttner V, Egeblad M. Communication in tiny packages: Exosomes as means of tumor-stroma communication. Biochimica et biophysica acta Reviews on cancer. 2020;1873(2):188340.CrossRefPubMed
21.
go back to reference Bi Y, Guo X, Zhang M, et al. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. Stem Cell Res Ther. 2021;12(1):602.CrossRefPubMedPubMedCentral Bi Y, Guo X, Zhang M, et al. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. Stem Cell Res Ther. 2021;12(1):602.CrossRefPubMedPubMedCentral
22.
go back to reference Liu J, Sun Y, Zhu B, et al. Identification of a potentially novel LncRNA-miRNA-mRNA competing endogenous RNA network in pulmonary arterial hypertension via integrated bioinformatic analysis. Life sciences. 2021;277:119455.CrossRefPubMed Liu J, Sun Y, Zhu B, et al. Identification of a potentially novel LncRNA-miRNA-mRNA competing endogenous RNA network in pulmonary arterial hypertension via integrated bioinformatic analysis. Life sciences. 2021;277:119455.CrossRefPubMed
23.
go back to reference Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16(1):220.CrossRefPubMedPubMedCentral Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16(1):220.CrossRefPubMedPubMedCentral
24.
go back to reference Wang X, Fang L. Advances in circular RNAs and their roles in breast Cancer. Journal of experimental & clinical cancer research: CR. 2018;37(1):206.CrossRefPubMedCentral Wang X, Fang L. Advances in circular RNAs and their roles in breast Cancer. Journal of experimental & clinical cancer research: CR. 2018;37(1):206.CrossRefPubMedCentral
25.
go back to reference Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL, Yang Y. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. Journal of experimental & clinical cancer research: CR. 2018;37(1):325.CrossRefPubMedCentral Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL, Yang Y. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. Journal of experimental & clinical cancer research: CR. 2018;37(1):325.CrossRefPubMedCentral
26.
go back to reference Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. International journal of medical sciences. 2019;16(2):292–301.CrossRefPubMedPubMedCentral Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. International journal of medical sciences. 2019;16(2):292–301.CrossRefPubMedPubMedCentral
27.
go back to reference Ma X, Yan W, Xu P, et al. LncRNA-p21 suppresses cell proliferation and induces apoptosis in gastric cancer by sponging miR-514b-3p and up-regulating ARHGEF9 expression. Biological chemistry. 2022;403(10):945–958.CrossRefPubMed Ma X, Yan W, Xu P, et al. LncRNA-p21 suppresses cell proliferation and induces apoptosis in gastric cancer by sponging miR-514b-3p and up-regulating ARHGEF9 expression. Biological chemistry. 2022;403(10):945–958.CrossRefPubMed
28.
go back to reference Ren LL, Yan TT, Shen CQ, et al. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis. Cell death & disease. 2018;9(6):687.CrossRef Ren LL, Yan TT, Shen CQ, et al. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis. Cell death & disease. 2018;9(6):687.CrossRef
29.
go back to reference Wu C, Wang Z, Tian X, Wang J, Zhang Y, Wu B. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis. Bioengineered. 2021;12(1):3772–3786.CrossRefPubMedPubMedCentral Wu C, Wang Z, Tian X, Wang J, Zhang Y, Wu B. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis. Bioengineered. 2021;12(1):3772–3786.CrossRefPubMedPubMedCentral
30.
go back to reference Yang C, Zang Y, Wu S, et al. Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma. Cell Death Discov. 2022;8(1):392.CrossRefPubMedPubMedCentral Yang C, Zang Y, Wu S, et al. Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma. Cell Death Discov. 2022;8(1):392.CrossRefPubMedPubMedCentral
31.
go back to reference Wang LC, Chen SH, Shen XL, et al. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme. Front Oncol. 2020;10:536875.CrossRefPubMedPubMedCentral Wang LC, Chen SH, Shen XL, et al. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme. Front Oncol. 2020;10:536875.CrossRefPubMedPubMedCentral
32.
go back to reference Zhu W, Wang J, Liu X, et al. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell death & disease. 2022;13(8):703.CrossRef Zhu W, Wang J, Liu X, et al. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell death & disease. 2022;13(8):703.CrossRef
33.
go back to reference Wang S, Xu G, Chao F, Zhang C, Han D, Chen G. HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer. Cancer management and research. 2021;13:7263–7276.CrossRefPubMedPubMedCentral Wang S, Xu G, Chao F, Zhang C, Han D, Chen G. HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer. Cancer management and research. 2021;13:7263–7276.CrossRefPubMedPubMedCentral
34.
go back to reference Wu Y, Zhao W, Liu Y, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. The EMBO journal 2018;37(23). Wu Y, Zhao W, Liu Y, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. The EMBO journal 2018;37(23).
35.
go back to reference Huang H, Han Y, Zhang C, et al. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(3):3527–3534.CrossRefPubMed Huang H, Han Y, Zhang C, et al. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(3):3527–3534.CrossRefPubMed
Metadata
Title
Hsa_circ_0014606 Derived from Exosomes Promotes Gastric Carcinoma Tumorigenesis and Proliferation by Sponging miR-514b-3p to Upregulate HNRNPC
Authors
Tao Jiang
Lingling Xu
Xiaona Qu
Rui Li
Ye Cheng
Hongmei He
Publication date
13-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08254-z

Other articles of this Issue 3/2024

Digestive Diseases and Sciences 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine